The companies will use clinical trial plasma samples and data to drive the AthosOmics.AI platform to identify efficacy biomarkers for Xeptiva's lead experimental therapeutic vaccine for canine ...
Najar, the expert in SaaS investment management and optimization for enterprises, reports strong adoption of its procurement solutions and presents its strategic roadmap to support its European ...
UBS Global Healthcare Conference 2025 November 10, 2025 8:00 AM ESTCompany ParticipantsMaxwell Krakowiak - Senior VP ...
Sartorius AG is rebounding with strong bioprocess segment growth and improving profit margins, despite a challenging ...
In vivo preclinical proof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduction in non-human primates ...
The world needs more food, and traditional farming isn’t always cutting it anymore. Weather’s gotten weird, and ...
Ex vivo lung perfusion (EVLP) provides a platform for testing therapies but faces challenges in standardizing drug evaluation. At AAPS PharmSci 360, Xuanzi Zhou says digital twins accurately predict ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback